NCJ Number
122631
Date Published
1988
Length
69 pages
Annotation
The Federal Bureau of Investigation (FBI) has developed an employee drug deterrence program that encompasses drug testing, employee assistance, supervisory training, and disciplinary actions.
Abstract
The development of an FBI policy to deter illegal drug use through compulsory urinalysis began in late 1983. The FBI's Inspection Division conducted a policy review of employee urine testing after the manager of a large field office voiced concern over the apparent lack of clearly defined policies and suggested that requiring employees to submit urine specimens would greatly enhance the ability of managers to identify illegal drug use. In 1985, two events facilitated the development of a comprehensive drug testing program. First, it was widely reported in the press that major corporations were instituting drug testing programs, with particular emphasis on pre-employment screening. Second, the FBI Director and the Drug Enforcement Agency determined that both investigative agencies responsible for Federal drug law enforcement should take the initiative and develop model employee drug testing programs. The FBI has documented that its special agents and support employees are susceptible to illegal drug use. Therefore, the FBI drug deterrence program focuses on drugs to be screened, detection methods, specimen collection procedures, reporting procedures, employee assistance, supervisory training and responsibilities, recordkeeping and confidentiality, and disciplinary actions. Further information on drug testing guidelines and procedures is appended.